Advertisement

Picture EBD Group BIO-Europe 2019 Partnering Open BEU2019 650x80px
Document › Details

Bayer AG. (7/31/19). "Press Release: U.S. FDA Approves Darolutamide, a New Treatment for Men with Non-metastatic Castration-resistant Prostate Cancer [Not intended for U.S. and UK Media]". Berlin.

Region Region United States (USA)
Organisations Organisation Bayer AG
  Group Bayer (Group)
  Organisation 2 FDA (US Food and Drug Administration)
  Group United States (govt)
Products Product Nubeqa®
  Product 2 phase 3 study
Index term Index term Bayer–Orion Corp: cancer drug, 201412 existent collab ww developm + marketing of oral androgen receptor modulator ODM-201 for prostate cancer
Person Person LaCaze, Robert (Bayer 201702– EVP of new Oncology Strategic Business Unit joined 2015 from BMS)
     


   
Record changed: 2019-07-31

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

More documents for Bayer (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BIO-Europe 2019 Partnering Report BEU2019 650x80px




» top